KIORA PHARMACEUTICALS, INC. Preferred Stock, Shares Outstanding
KIORA PHARMACEUTICALS, INC. (KPRX) had Preferred Stock, Shares Outstanding of 0 shares as of 2017-03-31, per its 10-Q filed 2017-05-05.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2017-05-05
- 2017-03-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2016-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2016-09-30: Preferred Stock, Shares Outstanding 1.23K shares.
- 2016-06-30: Preferred Stock, Shares Outstanding 2.65K shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-05 |
| 2016-12-31 | 0.00 shares 10-Q · filed 2017-05-05 |
| 2016-09-30 | 1.23K shares 10-Q · filed 2016-11-01 |
| 2016-06-30 | 2.65K shares 10-Q · filed 2016-08-10 |
| 2015-12-31 | 0.00 shares 10-K · filed 2017-02-23 |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-12 |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-12 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-18 |
| 2014-12-31 | 0.00 shares 10-Q · filed 2015-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |